Tardive dyskinesia (TD) is caused by taking medications that block dopamine receptors in the brain, most commonly antipsychotic drugs. It develops as a side effect of these medications, not from an infection, lifestyle choice, or injury. The involuntary movements of the face, tongue, limbs, and trunk that define TD can appear after weeks, months, or years of treatment, and in some cases, they persist even after the medication is stopped.
The Main Cause: Dopamine-Blocking Medications
TD develops when medications repeatedly block dopamine receptors in the parts of your brain that control movement. Over time, those receptors become hypersensitive to dopamine. When dopamine does reach them, they overreact, triggering involuntary movements like lip smacking, tongue thrusting, or finger wiggling. Think of it like turning up the volume on a speaker that’s been muffled for too long: once the signal gets through, the response is exaggerated and hard to control.
The medications most likely to cause TD are antipsychotics, which are prescribed for conditions like schizophrenia, bipolar disorder, and sometimes severe depression or anxiety. Older antipsychotics (sometimes called “typical” or first-generation) carry the highest risk. In studies of older adults taking these drugs, the cumulative incidence of TD reached 29% after one year and climbed to 63% after three years. Newer atypical antipsychotics carry a lower but still real risk. In the same high-risk population, the six-month incidence was about 24% for newer drugs compared to nearly 45% for older ones. At lower doses, some newer antipsychotics showed annual rates as low as 1% to 3%.
Non-Psychiatric Drugs That Also Cause TD
You don’t have to be taking a psychiatric medication to develop TD. One of the most common non-psychiatric causes is metoclopramide, a drug prescribed for nausea, acid reflux, and gastroparesis. The FDA placed a black box warning on metoclopramide stating that it can cause TD that is “often irreversible,” and that treatment lasting longer than 12 weeks should be avoided in nearly all cases. About 20% of people prescribed metoclopramide end up taking it longer than that recommended window. The risk rises with higher cumulative doses and longer use.
Other medication classes linked to TD include:
- Antidepressants: certain SSRIs, tricyclics, and MAOIs
- Anti-nausea drugs: prochlorperazine, in addition to metoclopramide
- Anti-seizure medications: carbamazepine, phenytoin, phenobarbital
- Mood stabilizers: lithium
- Stimulants: amphetamine, methylphenidate
- Antihistamines and decongestant combinations
- Parkinson’s disease medications: levodopa and related drugs
The risk from most of these non-antipsychotic drugs is considerably lower than from antipsychotics, but it exists. Many people taking these medications have no idea TD is a possible side effect.
Who Is Most at Risk
Anyone taking a dopamine-blocking drug can develop TD, but certain groups face higher odds. Your risk increases after age 40, and adults over 65 have the highest rates, likely because of age-related changes in brain chemistry. Women have a slightly higher risk than men overall, and postmenopausal women are particularly vulnerable. One study found that postmenopausal individuals developed TD at rates as high as 30% after roughly one year of antipsychotic use.
People with diabetes also appear to face elevated risk, though the reasons aren’t fully understood. Genetics play a role too. Researchers have identified variations in genes related to dopamine receptors, serotonin receptors, and the brain’s ability to handle oxidative stress that may make some people more susceptible. This helps explain why two people on the same medication at the same dose can have very different outcomes: one develops TD and the other doesn’t.
Higher doses and longer treatment duration consistently increase risk across all groups. There’s no safe minimum duration that guarantees you won’t develop TD, but shorter exposure at the lowest effective dose reduces the likelihood.
What TD Looks and Feels Like
TD most often shows up in the face and mouth first. You might notice involuntary lip puckering, tongue movements (the tongue pushing against your cheek or darting in and out), jaw clenching, or exaggerated blinking and grimacing. These movements happen on their own, without your intention, and you may not even notice them at first. Other people sometimes spot them before you do.
Beyond the face, TD can affect the arms, hands, legs, and feet. Movements in the limbs tend to look either rapid and jerky or slow and writhing. Finger tapping, foot squirming, and twisting of the ankles are common. In some cases, the trunk is involved, producing rocking, swaying, or pelvic movements. The severity varies widely. For some people, TD is subtle enough to be barely noticeable. For others, it’s physically disabling and socially isolating.
Clinicians assess TD using the Abnormal Involuntary Movement Scale (AIMS), which rates movements across seven body regions: facial muscles, lips, jaw, tongue, upper extremities, lower extremities, and trunk. If you’re on a medication known to cause TD, periodic AIMS assessments can catch the condition early.
Can TD Go Away?
TD is often permanent, which is what makes early detection so important. Remission rates depend heavily on how severe the movements are and how long they’ve been present before the offending medication is stopped. Mild TD caught early has a better chance of improving or resolving once the drug is discontinued. Severe, long-standing TD is much less likely to reverse.
Stopping the medication doesn’t guarantee improvement, and it’s not always an option. Many people take antipsychotics for conditions like schizophrenia where discontinuing treatment would be dangerous. In those situations, the decision involves weighing the psychiatric benefits of the drug against the movement disorder it’s causing.
Two FDA-approved medications now exist specifically for TD. Both work by reducing the amount of dopamine available in the brain, which calms the overstimulated receptors driving the involuntary movements. These treatments can reduce the severity of TD but are not cures. They manage symptoms for as long as you take them. For people whose TD appeared after using metoclopramide or another non-essential medication, stopping the drug and waiting several weeks to months may lead to partial or complete remission, though this is not guaranteed.
Why Early Detection Matters
The single most important factor in TD outcomes is catching it early. Because TD can start subtly, with slight tongue movements or occasional lip pursing, it’s easy to dismiss or overlook. The condition can also be masked by the very drug causing it: the medication may partially suppress the involuntary movements, hiding the problem until the dose is changed or the drug is stopped. At that point, the TD may appear suddenly and be quite advanced.
If you’re taking any medication known to carry TD risk, paying attention to new or unusual movements in your face, hands, or feet gives you the best chance of catching it while it’s still mild and more likely to respond to a change in treatment.